Elsevier

Neurobiology of Aging

Volume 28, Issue 8, August 2007, Pages 1195-1205
Neurobiology of Aging

Impaired spatial memory in APP-overexpressing mice on a homocysteinemia-inducing diet

https://doi.org/10.1016/j.neurobiolaging.2006.05.035Get rights and content

Abstract

Consumption of a diet that significantly elevates homocysteine (homocysteinemia) induces cell death in the CA3 hippocampal subfield in amyloid precursor protein (APP) over-expressing transgenic mice but not in wild-type controls. We assessed behavioral and other neuropathological effects of a homocysteinemia-inducing diet in aged APP-overexpressing mice. Starting at 16–18 months of age, mice were fed either a treatment diet lacking folate, choline, and methionine, and supplemented with homocysteine, or a control diet containing normal amounts of folate, choline and methionine but no homocysteine. After 5 months on the experimental diets, performance on a delayed non-matching-to-position working-memory task was unimpaired. In contrast, spatial reference memory in the water maze was impaired in transgenic mice on the treatment diet. Transgenic mice had higher homocysteine levels than wild-type mice even when fed the control diet, suggesting an effect of genotype on homocysteine metabolism. Methyl-donor deficiency did not alter amyloid deposition in the transgenic mice. These results suggest that disrupted homocysteine metabolism may induce Aβ-associated memory impairments and neurodegeneration in APP overexpressing mice.

Introduction

One of the primary features of Alzheimer's disease is neuronal cell loss in the hippocampus and cerebral cortex, areas of the brain involved in memory and cognition. As neurons die, short-term memory fails, followed by a decline in language, reasoning, and the ability to perform everyday tasks. Although the cause of cell death in Alzheimer's disease is not known, considerable evidence implicates β-amyloid (Aβ), a 39–43 amino-acid peptide cleaved from the amyloid precursor protein (APP). Aβ has been shown to induce DNA damage and neuronal death in vitro, and memory deficits in vivo[22], [24], [38], [47]. When APP is overexpressed or abnormally cleaved, Aβ forms toxic oligomers that aggregate into amyloid plaques and are associated with age-related memory impairment [7], [47]. This process has been modeled in several APP-overexpressing transgenic mouse lines bearing mutations linked to familial Alzheimer's disease in humans [9], [14], [30].

Although such genetic factors are sufficient to cause Alzheimer's disease, most cases are sporadic and other potentially-modifiable risk factors may be required for pathogenesis. One such factor is homocysteinemia—elevated plasma levels of the non-protein forming, sulfur amino acid homocysteine. Homocysteinemia is associated with increased risk of Alzheimer's disease and stroke [39], and moderate elevations of plasma homocysteine in cognitively intact individuals are associated with increased risk of subsequent incident dementia [34].

The relationship of homocysteinemia to Alzheimer's disease is uncertain. At high concentrations, homocysteine is neuro- and vasotoxic. In addition, conditions that lead to homocysteinemia have been shown to increase vulnerability to primary brain insults in animal models [8], [40] and to inhibit the proliferation of hippocampal neuroprogenitor cells [19]. The effect of homocysteinemia on cell death has been studied in 10-month-old APP-overexpressing mice bearing the Swedish double mutation (K595N, M596L). Three months of a methyl-donor-free diet supplemented with homocysteine induced a reduction in the number of CA3 pyramidal cells in the APP transgenic mice but not in wild-type controls [18]. The CA1 subfield and soluble amyloid levels were unaffected by the homocysteinemia-inducing diet. It is not known whether the reduction in CA3 cell numbers in the homocysteinemic transgenic mice was due to increased neuronal death or to an inhibitory effect on neural progenitors, or both. Alzheimer's patients have a similar loss of cells in CA3, and lesions of this hippocampal subfield induce memory deficits in experimental animals [3], [11], [32], [35], [37]. The effect of the homocysteinemia-inducing diet on memory and neuropathology in APP-overexpressing mice is not known. The present experiments examined short-term working memory, spatial memory, and neuropathology in Tg2576 transgenic mice exposed to chronic homocysteinemia.

Section snippets

Study population

Female Tg2576 APP-overexpressing transgenic mice bearing the Swedish double mutation (K670N, M671L) were generated on a B6SJLF1 hybrid background [4], [14]. Wild-type X APP transgenic matings were used to produce hemizygous transgenic mice (n = 14) and wild-type littermate controls (n = 19) for all experiments. One transgenic mouse died after hidden-platform training in the water maze, but before cued-platform training. Because the retinal degeneration (rd) gene is known to segregate with the

Short-term working memory is unaffected by genotype or diet

All mice learned to perform the DNMTP task to criterion, and there was no effect of genotype on the rate of learning (data not shown). After 4 months of DNMTP training, mice were matched for performance and placed on the experimental diets. After 5 months on the diets, there was no effect of genotype [F(1,15) = 0.21, p = .651] or diet [F(1,15) = 1.40, p = .255] on the number of trials completed per session, and no Genotype X Diet interaction [F(1,15) = 1.02, p = .329]. This suggests that the diets did not

Discussion

The treatment diet significantly impaired spatial learning and memory in old Tg2576 mice. Age-matched wild-type littermates were unaffected by the same diet. In contrast, short-term working memory was unimpaired in transgenics fed the treatment diet. The cognitive deficit could not be attributed to greater amyloid aggregation, as the treatment diet did not significantly affect plaque load in Tg2576 mice. Thus the combination of Aβ overexpression with long-term dietary metabolic stress that

Acknowledgements

This work was supported by the National Institute of Aging (AG022439), the National Institute of Child Health and Development (HD015052), and the U.S. Department of Agriculture under cooperative agreement No. 58-1950-9-001. Some of the behavioral experiments were conducted within the Murine Neurobehavioral Laboratory core facility (www.medschool.mc.vanderbilt.edu/mnl).

References (47)

  • W.A. Sweeney et al.

    Intrahippocampal injections of exogenous beta-amyloid induce postdelay errors in an eight-arm radial maze

    Neurobiol Learn Mem

    (1997)
  • A.M. Troen

    The central nervous system in animal models of hyperhomocysteinemia

    Prog Neuropsychopharmacol Biol Psychiatry

    (2005)
  • T.M. Wengenack et al.

    Quantitative histological analysis of amyloid deposition in Alzheimer's double transgenic mouse brain

    Neuroscience

    (2000)
  • X. Blaizot et al.

    Correlations between visual recognition memory and neocortical and hippocampal glucose metabolism after bilateral rhinal cortex lesions in the baboon: implications for Alzheimer's disease

    J Neurosci

    (2002)
  • M. Bobinski et al.

    Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease

    J Neuropathol Exp Neurol

    (1997)
  • P.F. Chapman et al.

    Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice

    Nat Neurosci

    (1999)
  • Z. Chen et al.

    Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition

    Hum Mol Genet

    (2001)
  • R. Clarke et al.

    Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease

    Arch Neurol

    (1998)
  • J.P. Cleary et al.

    Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function

    Nat Neurosci

    (2005)
  • W. Duan et al.

    Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease

    J Neurochem

    (2002)
  • D. Games et al.

    Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein

    Nature

    (1995)
  • L. Ho et al.

    Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease

    Arch Neurol

    (2001)
  • P.R. Hof et al.

    Comparative cytoarchitectonic atlas of the C57BL6 and 129Sv mouse brains

    (2000)
  • Cited by (0)

    View full text